Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Si-Bone Inc
(NQ:
SIBN
)
14.17
+0.30 (+2.16%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Si-Bone Inc
< Previous
1
2
3
Next >
Analyst Ratings For SI-BONE
August 06, 2024
Via
Benzinga
These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results
August 06, 2024
Via
Benzinga
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via
InvestorPlace
A Closer Look at 6 Analyst Recommendations For SI-BONE
May 07, 2024
Via
Benzinga
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
March 28, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock
February 27, 2024
Via
Benzinga
Recap: SI-BONE Q4 Earnings
February 26, 2024
Via
Benzinga
SI-BONE's Earnings Outlook
February 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 27, 2024
Via
Benzinga
Where SI-BONE Stands With Analysts
November 07, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Analyst Ratings for SI-BONE
September 26, 2023
Via
Benzinga
Analyst Ratings for SI-BONE
August 08, 2023
Via
Benzinga
Earnings Preview: SI-BONE
August 04, 2023
Via
Benzinga
The Latest Analyst Ratings for SI-BONE
July 19, 2023
Via
Benzinga
Why Shares of Si-Bone Jumped Tuesday
May 02, 2023
The company reported first-quarter earnings and improved revenue guidance.
Via
The Motley Fool
Canaccord Genuity Maintains Buy Rating for SI-BONE: Here's What You Need To Know
May 02, 2023
Via
Benzinga
Earnings Scheduled For February 26, 2024
February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
Via
Benzinga
What Analysts Are Saying About SI-BONE Stock
December 22, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About SI-BONE
December 04, 2023
Via
Benzinga
Cantor Fitzgerald Maintains Overweight Rating for SI-BONE: Here's What You Need To Know
November 07, 2023
Via
Benzinga
SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches
July 12, 2023
Needham analyst David Saxon reiterated a Buy rating on SI-BONE, Inc (NASDAQ: SIBN),
Via
Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
The Latest Analyst Ratings for SI-BONE
May 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns
May 02, 2023
U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to...
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.